0 Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy

被引:7
|
作者
Shinohara, Tsuyoshi [1 ]
Yamada, Hiroyuki [1 ]
Fujimori, Yoshiro [1 ]
Yamagishi, Kiyofumi [1 ]
机构
[1] Hokushir Gen Hosp, Dept Surg, Nakaro, Nagano, Japan
来源
关键词
malignant pleural effusion; breast cancer; late recurrence; endocrine therapy;
D O I
10.12659/AJCR.889249
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The most common site of postoperative breast cancer recurrence is bone, followed by local relapse, lung, and liver. The majority of relapses occur within the first 3 years after surgery. Pleural recurrences more than 10 years after surgery are rare. Case Report: A 94-year-old woman who had undergone modified radical mastectomy for right breast cancer (invasive ductal carcinoma, pT2, pN1, ER+, PgR+) 12 years earlier presented to our hospital with carcinomatous pleuritis and a chief complaint of dyspnea. Endocrine therapy with oral letrozole was started and the pleural effusion had disappeared 3 months later. Conclusions: Oral endocrine therapy may be effective for the treatment of late recurrence of hormon receptor-positive breast cancer in elderly women.
引用
收藏
页码:184 / 187
页数:4
相关论文
共 50 条
  • [41] A Case of Locally Advanced Breast Cancer Successfully Treated with Multidisciplinary Therapy
    Tomita, Masafumi
    Oura, Shoji
    Makimoto, Shinichiro
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 261 - 265
  • [42] Prognosis for Isolated Skin Recurrence after Breast Cancer Treated by Mastectomy
    Jaffre, Frederique
    Lavoue, Vincent
    Mesbah, Habiba
    Rouquette, Sophie
    Audrain, Odile
    Laurent, Jean Francois
    Leveque, Jean
    ANTICANCER RESEARCH, 2009, 29 (05) : 1697 - 1701
  • [43] Experiences of endocrine therapy after breast cancer surgery
    Karlsson, S. Ahlstedt
    Bagge, R. Olofsson
    Henoch, I.
    Wallengren, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [44] Breast cancer metastatic to the colon 20 years after bilateral mastectomy
    Defrawi, T.
    Goyal, A.
    Duan, X.
    Kott, M.
    Fischer, C. P.
    Adler, D. G.
    ENDOSCOPY, 2006, 38 : E1 - E1
  • [45] Gene therapy for lung cancer malignant pleural effusion: current and future nano-biotechnology
    Zarogoulidis, Paul
    Domvri, Kalliopi
    Huang, Haidong
    Zarogoulidis, Konstantinos
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (04) : 234 - 237
  • [46] Contralateral breast cancer risk and endocrine therapy use in patients with ductal carcinoma in situ treated with unilateral mastectomy in the modern era
    ElSherif, Ayat S.
    Tu, Chao
    Valente, Stephanie A.
    AMERICAN JOURNAL OF SURGERY, 2021, 221 (03): : 521 - 524
  • [47] Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis
    Chen, Onathan
    Wu, Xian
    Christos, Paul
    Yan, Weisi
    Ravi, Akkamma
    CLINICAL BREAST CANCER, 2018, 18 (05) : E967 - E973
  • [48] Non-adherence to endocrine therapy is associated with a significant increased risk of local recurrence in women ≥65 years with stage T1N0 breast cancer treated with adjuvant endocrine therapy alone after breast-conserving surgery
    Goldberg, Mira
    Sutradhar, Rinku
    Paszat, Lawrence
    Whelan, Timothy
    Gu, Sumei
    Fong, Cindy
    Rakovitch, Eileen
    CANCER RESEARCH, 2020, 80 (04)
  • [49] First-line systemic therapy for metastatic breast cancer and management of pleural effusion
    Perrone, F
    Carlomagno, C
    DePlacido, S
    Lauria, R
    Morabito, A
    Bianco, AR
    ANNALS OF ONCOLOGY, 1995, 6 (10) : 1033 - 1043
  • [50] Prognostic factors of mortality after palliative procedures in patients ECOG 0-2 with malignant pleural effusion
    Abrao, Fernando
    Abreu, Igor
    Campello, Mariana
    Garcia, Geisa
    D'Alpino, Renata D'Alpino
    Younes, Riad N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)